Skip to content

06622.HK

Zhaoke Ophthalmology Limited

HKSE · Healthcare · Biotechnology · CN

HKD 2.53
+1.61%
Ask drillr
  • Aug 12, 2026, 09:02 UTC

    Zhaoke Ophthalmology signed an exclusive distribution and promotion agreement with Pengpai Biomedical for its epinastine hydrochloride eye drops (brand: Mingyanshu) covering all sales channels in mainland China, with an initial five-year term and possible extension to ten years.